 | • レポートコード：MRC2Q12-16822 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、末梢神経損傷治療のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 末梢神経損傷治療のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 末梢神経損傷治療の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 末梢神経損傷治療のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの末梢神経損傷治療の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の末梢神経損傷治療の売上および2028年までの予測に焦点を当てています。 末梢神経損傷治療のグローバル主要企業には、AxoGen, Inc.、Stryker、Baxter International, Inc、POLYGANICS BV、Integra Lifesciences Corporation、Renerva, LLC.、Medovent GmbH、Toyobo Co., Ltdなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 末梢神経損傷治療市場は、タイプとアプリケーションによって区分されます。世界の末梢神経損傷治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 神経コンジット、神経プロテクター、神経コネクター、神経ラップ 【アプリケーション別セグメント】 運動神経、感覚神経、自律神経 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 末梢神経損傷治療製品概要 - タイプ別市場（神経コンジット、神経プロテクター、神経コネクター、神経ラップ） - アプリケーション別市場（運動神経、感覚神経、自律神経） - 調査の目的 ・エグゼクティブサマリー - 世界の末梢神経損傷治療販売量予測2017-2028 - 世界の末梢神経損傷治療売上予測2017-2028 - 末梢神経損傷治療の地域別販売量 - 末梢神経損傷治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別末梢神経損傷治療販売量 - 主要メーカー別末梢神経損傷治療売上 - 主要メーカー別末梢神経損傷治療価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（神経コンジット、神経プロテクター、神経コネクター、神経ラップ） - 末梢神経損傷治療のタイプ別販売量 - 末梢神経損傷治療のタイプ別売上 - 末梢神経損傷治療のタイプ別価格 ・アプリケーション別市場規模（運動神経、感覚神経、自律神経） - 末梢神経損傷治療のアプリケーション別販売量 - 末梢神経損傷治療のアプリケーション別売上 - 末梢神経損傷治療のアプリケーション別価格 ・北米市場 - 北米の末梢神経損傷治療市場規模（タイプ別、アプリケーション別） - 主要国別の末梢神経損傷治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの末梢神経損傷治療市場規模（タイプ別、アプリケーション別） - 主要国別の末梢神経損傷治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の末梢神経損傷治療市場規模（タイプ別、アプリケーション別） - 主要国別の末梢神経損傷治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の末梢神経損傷治療市場規模（タイプ別、アプリケーション別） - 主要国別の末梢神経損傷治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの末梢神経損傷治療市場規模（タイプ別、アプリケーション別） - 主要国別の末梢神経損傷治療市場規模（トルコ、サウジアラビア） ・企業情報 AxoGen, Inc.、Stryker、Baxter International, Inc、POLYGANICS BV、Integra Lifesciences Corporation、Renerva, LLC.、Medovent GmbH、Toyobo Co., Ltd ・産業チェーン及び販売チャネル分析 - 末梢神経損傷治療の産業チェーン分析 - 末梢神経損傷治療の原材料 - 末梢神経損傷治療の生産プロセス - 末梢神経損傷治療の販売及びマーケティング - 末梢神経損傷治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 末梢神経損傷治療の産業動向 - 末梢神経損傷治療のマーケットドライバー - 末梢神経損傷治療の課題 - 末梢神経損傷治療の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Peripheral Nerve Injuries Therapeutic estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Peripheral Nerve Injuries Therapeutic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Peripheral Nerve Injuries Therapeutic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Peripheral Nerve Injuries Therapeutic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Peripheral Nerve Injuries Therapeutic include AxoGen, Inc., Stryker, Baxter International, Inc, POLYGANICS BV, Integra Lifesciences Corporation, Renerva, LLC., Medovent GmbH and Toyobo Co., Ltd, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Peripheral Nerve Injuries Therapeutic companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Peripheral Nerve Injuries Therapeutic market. Further, it explains the major drivers and regional dynamics of the global Peripheral Nerve Injuries Therapeutic market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
AxoGen, Inc.
Stryker
Baxter International, Inc
POLYGANICS BV
Integra Lifesciences Corporation
Renerva, LLC.
Medovent GmbH
Toyobo Co., Ltd
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Peripheral Nerve Injuries Therapeutic Segment by Type
Nerve Conduit
Nerve Protector
Nerve Connector
Nerve Wraps
Peripheral Nerve Injuries Therapeutic Segment by Application
Motor Nerves
Sensory Nerves
Autonomic Nerves
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Peripheral Nerve Injuries Therapeutic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Peripheral Nerve Injuries Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Peripheral Nerve Injuries Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Peripheral Nerve Injuries Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Peripheral Nerve Injuries Therapeutic revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Peripheral Nerve Injuries Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Peripheral Nerve Injuries Therapeutic revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AxoGen, Inc., Stryker, Baxter International, Inc, POLYGANICS BV, Integra Lifesciences Corporation, Renerva, LLC., Medovent GmbH and Toyobo Co., Ltd, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Peripheral Nerve Injuries Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Nerve Injuries Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peripheral Nerve Injuries Therapeutic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Nerve Injuries Therapeutic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Nerve Conduit
1.2.3 Nerve Protector
1.2.4 Nerve Connector
1.2.5 Nerve Wraps
1.3 Market by Application
1.3.1 Global Peripheral Nerve Injuries Therapeutic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Motor Nerves
1.3.3 Sensory Nerves
1.3.4 Autonomic Nerves
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Nerve Injuries Therapeutic Market Perspective (2017-2028)
2.2 Peripheral Nerve Injuries Therapeutic Growth Trends by Region
2.2.1 Peripheral Nerve Injuries Therapeutic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Peripheral Nerve Injuries Therapeutic Historic Market Size by Region (2017-2022)
2.2.3 Peripheral Nerve Injuries Therapeutic Forecasted Market Size by Region (2023-2028)
2.3 Peripheral Nerve Injuries Therapeutic Market Dynamics
2.3.1 Peripheral Nerve Injuries Therapeutic Industry Trends
2.3.2 Peripheral Nerve Injuries Therapeutic Market Drivers
2.3.3 Peripheral Nerve Injuries Therapeutic Market Challenges
2.3.4 Peripheral Nerve Injuries Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Nerve Injuries Therapeutic Players by Revenue
3.1.1 Global Top Peripheral Nerve Injuries Therapeutic Players by Revenue (2017-2022)
3.1.2 Global Peripheral Nerve Injuries Therapeutic Revenue Market Share by Players (2017-2022)
3.2 Global Peripheral Nerve Injuries Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Nerve Injuries Therapeutic Revenue
3.4 Global Peripheral Nerve Injuries Therapeutic Market Concentration Ratio
3.4.1 Global Peripheral Nerve Injuries Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Nerve Injuries Therapeutic Revenue in 2021
3.5 Peripheral Nerve Injuries Therapeutic Key Players Head office and Area Served
3.6 Key Players Peripheral Nerve Injuries Therapeutic Product Solution and Service
3.7 Date of Enter into Peripheral Nerve Injuries Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Nerve Injuries Therapeutic Breakdown Data by Type
4.1 Global Peripheral Nerve Injuries Therapeutic Historic Market Size by Type (2017-2022)
4.2 Global Peripheral Nerve Injuries Therapeutic Forecasted Market Size by Type (2023-2028)
5 Peripheral Nerve Injuries Therapeutic Breakdown Data by Application
5.1 Global Peripheral Nerve Injuries Therapeutic Historic Market Size by Application (2017-2022)
5.2 Global Peripheral Nerve Injuries Therapeutic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Peripheral Nerve Injuries Therapeutic Market Size (2017-2028)
6.2 North America Peripheral Nerve Injuries Therapeutic Market Size by Type
6.2.1 North America Peripheral Nerve Injuries Therapeutic Market Size by Type (2017-2022)
6.2.2 North America Peripheral Nerve Injuries Therapeutic Market Size by Type (2023-2028)
6.2.3 North America Peripheral Nerve Injuries Therapeutic Market Share by Type (2017-2028)
6.3 North America Peripheral Nerve Injuries Therapeutic Market Size by Application
6.3.1 North America Peripheral Nerve Injuries Therapeutic Market Size by Application (2017-2022)
6.3.2 North America Peripheral Nerve Injuries Therapeutic Market Size by Application (2023-2028)
6.3.3 North America Peripheral Nerve Injuries Therapeutic Market Share by Application (2017-2028)
6.4 North America Peripheral Nerve Injuries Therapeutic Market Size by Country
6.4.1 North America Peripheral Nerve Injuries Therapeutic Market Size by Country (2017-2022)
6.4.2 North America Peripheral Nerve Injuries Therapeutic Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Peripheral Nerve Injuries Therapeutic Market Size (2017-2028)
7.2 Europe Peripheral Nerve Injuries Therapeutic Market Size by Type
7.2.1 Europe Peripheral Nerve Injuries Therapeutic Market Size by Type (2017-2022)
7.2.2 Europe Peripheral Nerve Injuries Therapeutic Market Size by Type (2023-2028)
7.2.3 Europe Peripheral Nerve Injuries Therapeutic Market Share by Type (2017-2028)
7.3 Europe Peripheral Nerve Injuries Therapeutic Market Size by Application
7.3.1 Europe Peripheral Nerve Injuries Therapeutic Market Size by Application (2017-2022)
7.3.2 Europe Peripheral Nerve Injuries Therapeutic Market Size by Application (2023-2028)
7.3.3 Europe Peripheral Nerve Injuries Therapeutic Market Share by Application (2017-2028)
7.4 Europe Peripheral Nerve Injuries Therapeutic Market Size by Country
7.4.1 Europe Peripheral Nerve Injuries Therapeutic Market Size by Country (2017-2022)
7.4.2 Europe Peripheral Nerve Injuries Therapeutic Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Size (2017-2028)
8.2 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Size by Type
8.2.1 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Share by Type (2017-2028)
8.3 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Size by Application
8.3.1 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Share by Application (2017-2028)
8.4 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Size by Region
8.4.1 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Peripheral Nerve Injuries Therapeutic Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peripheral Nerve Injuries Therapeutic Market Size (2017-2028)
9.2 Latin America Peripheral Nerve Injuries Therapeutic Market Size by Type
9.2.1 Latin America Peripheral Nerve Injuries Therapeutic Market Size by Type (2017-2022)
9.2.2 Latin America Peripheral Nerve Injuries Therapeutic Market Size by Type (2023-2028)
9.2.3 Latin America Peripheral Nerve Injuries Therapeutic Market Share by Type (2017-2028)
9.3 Latin America Peripheral Nerve Injuries Therapeutic Market Size by Application
9.3.1 Latin America Peripheral Nerve Injuries Therapeutic Market Size by Application (2017-2022)
9.3.2 Latin America Peripheral Nerve Injuries Therapeutic Market Size by Application (2023-2028)
9.3.3 Latin America Peripheral Nerve Injuries Therapeutic Market Share by Application (2017-2028)
9.4 Latin America Peripheral Nerve Injuries Therapeutic Market Size by Country
9.4.1 Latin America Peripheral Nerve Injuries Therapeutic Market Size by Country (2017-2022)
9.4.2 Latin America Peripheral Nerve Injuries Therapeutic Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Size (2017-2028)
10.2 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Size by Type
10.2.1 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Share by Type (2017-2028)
10.3 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Size by Application
10.3.1 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Share by Application (2017-2028)
10.4 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Size by Country
10.4.1 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Peripheral Nerve Injuries Therapeutic Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AxoGen, Inc.
11.1.1 AxoGen, Inc. Company Details
11.1.2 AxoGen, Inc. Business Overview
11.1.3 AxoGen, Inc. Peripheral Nerve Injuries Therapeutic Introduction
11.1.4 AxoGen, Inc. Revenue in Peripheral Nerve Injuries Therapeutic Business (2017-2022)
11.1.5 AxoGen, Inc. Recent Developments
11.2 Stryker
11.2.1 Stryker Company Details
11.2.2 Stryker Business Overview
11.2.3 Stryker Peripheral Nerve Injuries Therapeutic Introduction
11.2.4 Stryker Revenue in Peripheral Nerve Injuries Therapeutic Business (2017-2022)
11.2.5 Stryker Recent Developments
11.3 Baxter International, Inc
11.3.1 Baxter International, Inc Company Details
11.3.2 Baxter International, Inc Business Overview
11.3.3 Baxter International, Inc Peripheral Nerve Injuries Therapeutic Introduction
11.3.4 Baxter International, Inc Revenue in Peripheral Nerve Injuries Therapeutic Business (2017-2022)
11.3.5 Baxter International, Inc Recent Developments
11.4 POLYGANICS BV
11.4.1 POLYGANICS BV Company Details
11.4.2 POLYGANICS BV Business Overview
11.4.3 POLYGANICS BV Peripheral Nerve Injuries Therapeutic Introduction
11.4.4 POLYGANICS BV Revenue in Peripheral Nerve Injuries Therapeutic Business (2017-2022)
11.4.5 POLYGANICS BV Recent Developments
11.5 Integra Lifesciences Corporation
11.5.1 Integra Lifesciences Corporation Company Details
11.5.2 Integra Lifesciences Corporation Business Overview
11.5.3 Integra Lifesciences Corporation Peripheral Nerve Injuries Therapeutic Introduction
11.5.4 Integra Lifesciences Corporation Revenue in Peripheral Nerve Injuries Therapeutic Business (2017-2022)
11.5.5 Integra Lifesciences Corporation Recent Developments
11.6 Renerva, LLC.
11.6.1 Renerva, LLC. Company Details
11.6.2 Renerva, LLC. Business Overview
11.6.3 Renerva, LLC. Peripheral Nerve Injuries Therapeutic Introduction
11.6.4 Renerva, LLC. Revenue in Peripheral Nerve Injuries Therapeutic Business (2017-2022)
11.6.5 Renerva, LLC. Recent Developments
11.7 Medovent GmbH
11.7.1 Medovent GmbH Company Details
11.7.2 Medovent GmbH Business Overview
11.7.3 Medovent GmbH Peripheral Nerve Injuries Therapeutic Introduction
11.7.4 Medovent GmbH Revenue in Peripheral Nerve Injuries Therapeutic Business (2017-2022)
11.7.5 Medovent GmbH Recent Developments
11.8 Toyobo Co., Ltd
11.8.1 Toyobo Co., Ltd Company Details
11.8.2 Toyobo Co., Ltd Business Overview
11.8.3 Toyobo Co., Ltd Peripheral Nerve Injuries Therapeutic Introduction
11.8.4 Toyobo Co., Ltd Revenue in Peripheral Nerve Injuries Therapeutic Business (2017-2022)
11.8.5 Toyobo Co., Ltd Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
| 【末梢神経損傷治療について】 末梢神経損傷は、身体の末梢にある神経が損傷を受け、感覚や運動機能に影響を与える状態を指します。この損傷は、外傷、圧迫、感染、炎症などさまざまな原因で発生することがあります。末梢神経損傷の治療は、損傷の程度や原因、患者の状態に応じて多岐にわたります。 まず、末梢神経の定義について考えてみましょう。末梢神経は、脊髄や脳から体の各部位に信号を伝える役割を持っており、運動神経、感覚神経、自律神経の3つのタイプに分類されます。運動神経は筋肉の動きを制御し、感覚神経は外部環境からの情報を脳に伝達します。また、自律神経は内臓機能を調整します。これらの神経が損傷を受けると、運動の制御ができなくなったり、感覚が失われたり、臓器の機能に異常が生じたりします。 次に、末梢神経損傷の特徴について見ていきます。末梢神経損傷は、症状の出方や進行の仕方、回復の可能性が多様です。軽度の神経損傷（神経の一時的な圧迫）は、休息や理学療法により自然に回復することが多いです。中程度から重度の神経損傷（神経の断裂や完全な切断）は、手術やリハビリテーションが必要になることが一般的です。また、症状は損傷を受けた神経の種類や部位によって異なります。一部の患者は痛みやしびれを感じる一方で、他の患者は運動機能の低下や感覚喪失を経験することもあります。 末梢神経の損傷には、主に以下のような種類があります。神経の圧迫が原因となる「圧迫性損傷」、外的な衝撃や切創によって神経が断裂する「外傷性損傷」、特定の疾病（糖尿病など）によって神経が弱体化する「病的損傷」があります。特に糖尿病に伴う末梢神経障害は、高血糖状態による神経の血流不足や代謝異常が影響し、慢性的な痺れや痛みを引き起こします。 治療方法には、保存療法と手術療法があります。保存療法は、リハビリテーション、理学療法、薬物療法などで構成されており、特に軽度の損傷の場合はこれらの方法で自然回復を助けることが期待されます。例えば、理学療法では、ストレッチや運動を通じて筋力を強化し、神経の再生を促進します。また、鎮痛薬や抗炎症薬も用いられ、痛みを軽減するサポートをします。 一方で、重度の損傷や運動機能に重大な影響が出ている場合には、手術が必要になることがあります。手術では、断裂した神経を縫合する「神経縫合手術」や、圧迫がある場合はその原因を取り除く「神経減圧手術」が行われます。また、神経移植や人工神経の使用も検討されることがあります。最近では、再生医療の技術が進展し、神経幹細胞を用いた治療法も研究されています。 さらに、最近の研究では、神経障害性疼痛に対する治療法も注目されています。神経障害性疼痛は、末梢神経損傷によって生じる痛みであり、通常の痛みと異なり、痛みを感じないはずの部位で痛みを感じることや、強い痛みを伴うことがあります。この疼痛の治療には、神経痛用の薬剤（カプサイシンパッチや、抗うつ薬など）が使用されることがあります。 リハビリテーションは、末梢神経損傷の治療において非常に重要な役割を果たします。理学療法士や作業療法士と協力し、効果的なリハビリ計画を立てることで、日常生活の質を向上させることができます。リハビリテーションには、筋力強化、柔軟性を保つ運動、バランス訓練などが含まれ、患者が自立して生活できるようサポートします。 また、最近の進展では、神経再生を促進するためのバイオエンジニアリング技術が注目されています。これには、3Dプリンティングを使った人工神経の作成や、生体材料を用いた神経再生支援デバイスの開発が含まれます。このような技術は、神経損傷後の回復をさらに加速させる可能性があります。 最後に、末梢神経損傷の治療には、患者の心理的サポートも重要です。慢性的な痛みや運動機能の低下によって、患者は精神的な負担を抱えることが多く、心のケアが回復を助ける要因となります。心理療法や地域のサポートグループへの参加により、患者が孤独を感じず、前向きに治療に臨むことができる環境を整えることが大切です。 末梢神経損傷の治療は、医療技術の進歩やリハビリテーションの発展により、患者の生活の質を向上させるためのさまざまな選択肢が用意されています。しかし、個々の症状や損傷の程度によって治療法は異なるため、専門医との密な連携によって最適な治療方針を選択することが重要です。末梢神経損傷の理解を深めることが、より良い治療と回復につながることを願っています。 |